Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen Sweetens Full-Year Outlook After Narrowly Beating Third-Quarter Forecasts
04:13pm, Thursday, 03'rd Nov 2022
Amgen topped third-quarter forecasts late Thursday and issued better-than-expected guidance for the year. Amgen stock was muted.
2 Dividend Stocks to Hold Through a Recession and Beyond
12:30pm, Thursday, 03'rd Nov 2022 The Motley Fool
If a recession does come, it won't be the first that these two companies will have survived one.
Can The Dow Jones Hold On To Recent Solid Gains?
12:41pm, Wednesday, 02'nd Nov 2022 Investing.com
20 dividend stocks that may be safest if the Federal Reserve causes a recession
07:26pm, Tuesday, 01'st Nov 2022 MarketWatch
Stocks with lower price volatility can serve as a safe haven for investors.
Pfizer (PFE) Beats on Q3 Earnings, Ups COVID Jab Sales View
03:39pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Pfizer (PFE) beats estimates for Q3 earnings and sales. It ups its sales and earnings view despite a decline in COVID-19 vaccine sales in Q3. Stock up in pre-market trading
Deal Activity Could Jumpstart Biotechnology
11:35pm, Monday, 31'st Oct 2022
Recent clinical successes and M&A could bring interest back to biotechnology, especially among mid-capitalization names with derisked or approved products. Restructuring, corporate activity, and COVID
Analyst Ratings for Amgen
06:52pm, Monday, 31'st Oct 2022 Benzinga
Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
2
2
2
0
Last 30D
0
0
0
Amgen (AMGN) to Report Q3 Earnings: What's in the Cards?
04:48pm, Monday, 31'st Oct 2022 Zacks Investment Research
Volume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
02:13pm, Monday, 31'st Oct 2022 Benzinga
Upgrades
Morgan Stanley upgraded the previous rating for Pure Storage Inc (NYSE:PSTG) from Equal-Weight to Overweight. In the second quarter, Pure Storage showed an EPS of $0.32, compared to $0.14 fr
6 Analysts Have This to Say About Amgen
02:01pm, Monday, 31'st Oct 2022 Benzinga
Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
2
2
2
0
Last 30D
0
0
0
What 6 Analyst Ratings Have To Say About Amgen
01:37pm, Monday, 31'st Oct 2022 Benzinga
Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
2
2
2
0
Last 30D
0
0
0
Why the Dow is having a killer month as it heads for best October ever
12:38pm, Monday, 31'st Oct 2022 MarketWatch
The Dow Jones Industrial Average has been criticized by some market watchers for being a poor barometer of equity-market performance given its relatively small sample size of just 30 stocks.
Take the Zacks Approach to Beat the Market: Caterpillar, Amgen, Inventiva in Focus
11:58am, Monday, 31'st Oct 2022 Zacks Investment Research
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Wall Street is being nicer on earnings as vaccine makers, fintech reports near
08:14pm, Sunday, 30'th Oct 2022 MarketWatch
With a downcast earnings season passing the halfway mark, results from pharma and fintech companies will dominate the week ahead.
3 Earnings to Watch Next Week
11:59am, Saturday, 29'th Oct 2022
The show must go on for Wall Street.
